ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant.

Authors	Till Holsten, Annika Bronsema, Dominik Sturm, Felix Sahm, Stefan Rutkowski, Ulrich Schüller, Wilhelm Wößmann, Uwe R Kordes
Journal	Pediatric blood & cancer (Pediatr Blood Cancer) Vol. 69 Issue 8 Pg. e29594 (08 2022) ISSN: 1545-5017 [Electronic] United States
PMID	35195346 (Publication Type: Letter)
Chemical References	Oncogene Proteins, Fusion Receptor Protein-Tyrosine Kinases
Topics	Gene Fusion Humans Lung Neoplasms (pathology) Oncogene Proteins, Fusion (genetics) Receptor Protein-Tyrosine Kinases (genetics) Salvage Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!